J., Chaikin, P., Colburn, W
however, the exact mechanism(s) underlying TNF hepatotoxicity in NAFLD remain to be clearly defined
Control hunger and lose weight with our available treatments
47 (Suppl 1): 13845
Ozempic was created and originally marketed towards people living with type 2 diabetes, however when using the medication on people with obesity researchers found that Ozempic had an incredibly positive effect on weight
Second, although SGLT2i monotherapy has been linked to improvements in fatty liver index and lower risk of MALO in MASLD patients, 12,15,28,29,30 , our findings suggest that adding GLP-1RA to SGLT2i provided additional hepatic benefits, reducing the risk of MALO by 39%